5 SIMPLE STATEMENTS ABOUT HEMGENIX EXPLAINED

Variety of qualified sufferers: CDEC talked about the uncertainty in the quantity of people with moderately severe to severe hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some patients who will be categorised as acquiring mild or average sickness can have a intense bleeding pheno